Silo Pharma gets notice of allowance for Canadian PTSD patent application
Silo Pharma (SILO) received a notice of allowance for a Canadian patent application covering a novel PTSD treatment, per the TradeXchange Newsdesk alert.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.